Matching slides 110,471
Current window 85,171-85,200
Pages 3,683
Rows per page 30
Component: Listclear collectionreset all

Component

85,171-85,200 of 110,471

filter-aware
04
The slide combines corporate facts with team and board composition.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations Beat · Team1 hit
07
The slide uses a hub-and-spoke diagram to illustrate data integration and a 2x2 matrix to represent the platform's core capabilities.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide uses a process flow diagram to illustrate how the platform generates assets which are then either developed in-house or out-licensed, alongside secondary collaboration models.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
14
The slide uses a split-layout with a dark sidebar for partnership specifics and a light main area for strategic benefits.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
15
The slide uses a list-based framework to demonstrate the 'Novel, Rapid, Effective' nature of their AI-driven discovery process.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
16
BenevolentAI | Investor Presentation Deck | 46 slidesBenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
17
The table presents financial data in thousands of pounds (£'000) for the six months ended June 30th.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations Beat · Financials1 hit
18
The slide uses a hub-and-spoke diagram to link the company to its five strategic capital allocation pillars.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations Beat · Financials1 hit
20
Includes explicit caveats regarding the small sample size and short duration of the Phase Ib study.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
24
BenevolentAI | Investor Presentation Deck | 46 slidesBenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
27
BenevolentAI | Investor Presentation Deck | 46 slidesBenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
29
The slide provides specific context for non-cash adjustments and working capital movements.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
31
The slide uses a hub-and-spoke style diagram to connect strategic pillars (Scientific, Commercial, etc.) to specific therapeutic area business models.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
32
The slide uses a 2x2 matrix to map specific industry players against two strategic dimensions.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
34
The slide uses a process flow diagram to illustrate data ingestion, NLP-based extraction, and the resulting knowledge graph.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
37
The slide uses a vertical timeline on the left to anchor the four steps: Tech Approach, Predict, Triage, and Assay.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
39
The slide uses a flowchart to illustrate the adaptive clinical trial design.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
40
The slide outlines a clinical trial process flow with specific durations and patient ratios.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
41
Includes multiple charts showing inhibition of cytokines and reduction of inflammation.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
42
The diagram uses a process flow to show where BEN-2293 fits into the treatment landscape relative to existing therapies.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
43
The slide uses a process flow framework to explain the drug discovery pipeline.BenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations 1 hit
04
SAD stands for Social Anxiety Disorder. The slide uses a metaphorical illustration of a person being scrutinized under a magnifying glass.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Problem1 hit
12
SAD stands for Social Anxiety Disorder.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
15
The slide outlines a standard clinical decision-making process for pharmacotherapy.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
19
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
22
The slide displays a snippet of the LSAS questionnaire, showing the scoring criteria for 'Fear or Anxiety' and 'Avoidance' and providing examples of the 24 items.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
23
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
25
The slide uses a nested bulleted list to define the three core components of a behavioral challenge.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
26
Bionomics | Investor Presentation Deck | 59 slidesBionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit
27
BNC210 refers to the Trier Social Stress Test (TSST) or a variant thereof used in clinical research.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Beat · Solution1 hit